Thirumalai Chemicals Limited has informed the Exchange regarding ''. Submission of Financial Statement for the Quarter and Financial Year ended 31st March 2025 in machine-readable and searchable form.
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.5 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Thirumalai Chemicals submitted its audited FY25 results along with the Board's decision to skip dividend for the year to conserve cash for ongoing projects. On a standalone basis, revenue grew 8.3% to ₹2,15,207 lakhs and profit after tax more than doubled to ₹8,221 lakhs (vs ₹3,630 lakhs in FY24), driven by better margins. On a consolidated basis, however, the company swung deeper into loss at ₹4,610 lakhs (vs ₹3,879 lakhs loss in FY24), hurt by losses in subsidiaries. Revenue at the consolidated level dipped slightly to ₹2,04,951 lakhs from ₹2,08,313 lakhs. Consolidated operating cash flow turned sharply negative at -₹6,588 lakhs (vs +₹23,705 lakhs in FY24) due to heavy capex of ₹61,290 lakhs into subsidiaries and projects. Borrowings rose meaningfully on the balance sheet, while cash and equivalents fell.
Mixed picture for shareholders: standalone business is healthy with strong PAT growth and no auditor qualifications, but consolidated losses are widening and cash burn from subsidiaries and project capex is significant. No dividend this year could weigh on income-focused investors, while the high capex and rising debt may pressure near-term returns despite the long-term growth push.